Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000520969 | SCV000620628 | uncertain significance | not provided | 2017-09-06 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the CACNA1A gene. The c.2108-15 C>T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.2108-15 C>T variant is observed in 2/6926 (0.03%) alleles from individuals of East Asian background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This substitution occurs at a position that is conserved in mammals. In-silico splice prediction models are not informative as to whether this variant will affect gene splicing. Additionally, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Fulgent Genetics, |
RCV000764183 | SCV000895185 | uncertain significance | Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002060279 | SCV002387246 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-01-22 | criteria provided, single submitter | clinical testing |